رجوع
نطاق اليوم
KWD 48.83
KWD 50.03
نطاق 52 أسبوعًا
KWD 38.24
KWD 62.15
حجم التداول
4,077
متوسط 50 يوم / 200 يوم
KWD 55.56
/
KWD 51.89
الإغلاق السابق
KWD 48.44
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 485.2 | 0.3 |
| P/B | 26.7 | 2.9 |
| ROE % | 5.4 | 3.7 |
| Net Margin % | 4.4 | 3.8 |
| Rev Growth 5Y % | -0.4 | 10.0 |
| D/E | 1.7 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2027 |
KWD 0.000
KWD 0.000 – KWD 0.000
|
3.5 B | 0 |
| FY2026 |
KWD 0.000
KWD 0.000 – KWD 0.000
|
3.2 B | 0 |
النقاط الرئيسية
Revenue declined -0.37% annually over 5 years
Earnings grew 77.13% over the past year
Generating 205.65M in free cash flow
P/E of 485.17 — premium valuation
Cash machine — converts 138.22% of earnings into free cash flow
النمو
Revenue Growth (5Y)
-0.37%
Revenue (1Y)0.53%
Earnings (1Y)77.13%
FCF Growth (3Y)-16.35%
الجودة
Return on Equity
5.44%
ROIC6.56%
Net Margin4.38%
Op. Margin18.41%
الأمان
Debt / Equity
1.65
Current Ratio0.90
Interest Coverage3.29
التقييم
P/E Ratio
485.17
P/B Ratio26.68
EV/EBITDA121.62
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0.53% | Revenue Growth (3Y) | 0.04% |
| Earnings Growth (1Y) | 77.13% | Earnings Growth (3Y) | -14.85% |
| Revenue Growth (5Y) | -0.37% | Earnings Growth (5Y) | -17.35% |
| Profitability | |||
| Revenue (TTM) | 3.40B | Net Income (TTM) | 148.79M |
| ROE | 5.44% | ROA | 1.53% |
| Gross Margin | 46.26% | Operating Margin | 18.41% |
| Net Margin | 4.38% | Free Cash Flow (TTM) | 205.65M |
| ROIC | 6.56% | FCF Growth (3Y) | -16.35% |
| Safety | |||
| Debt / Equity | 1.65 | Current Ratio | 0.90 |
| Interest Coverage | 3.29 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 485.17 | P/B Ratio | 26.68 |
| P/S Ratio | 21.24 | PEG Ratio | 1.47 |
| EV/EBITDA | 121.62 | Dividend Yield | 0.00% |
| Market Cap | 72.19B | Enterprise Value | 76.10B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.40B | 3.38B | 3.40B | 4.17B | 3.45B |
| Net Income | 148.79M | 84.00M | 205.20M | 678.10M | 318.90M |
| EPS (Diluted) | 0.43 | 0.24 | 0.60 | 2.67 | 1.25 |
| Gross Profit | 1.57B | 1.52B | 1.57B | 2.20B | 1.84B |
| Operating Income | 625.69M | 437.20M | 543.90M | 1.14B | 933.40M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 9.71B | 10.10B | 9.76B | 6.98B | 5.70B |
| Total Liabilities | 5.85B | 6.21B | 7.00B | 4.32B | 3.98B |
| Shareholders' Equity | 2.71B | 2.76B | 2.07B | 1.99B | 1.26B |
| Total Debt | 4.45B | 4.56B | 5.31B | 2.54B | 2.08B |
| Cash & Equivalents | 541.17M | 813.40M | 379.20M | 165.90M | 342.80M |
| Current Assets | 1.77B | 2.11B | 1.96B | 2.02B | 1.80B |
| Current Liabilities | 1.97B | 1.44B | 1.33B | 1.80B | 1.55B |